Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bruker Corporation stock logo
BRKR
Bruker
$35.28
-1.8%
$32.98
$28.53
$65.25
$5.45B1.24.03 million shs3.70 million shs
Cambrex Co. stock logo
CBM
Cambrex
$59.99
$59.99
$33.80
$60.29
$2.02B2.14218,726 shsN/A
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
$0.42
-5.0%
$0.47
$0.28
$2.82
$19.68M1.521.08 million shs748,369 shs
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
$1.42
-7.2%
$1.31
$0.85
$2.72
$459.57M2.16.87 million shs8.72 million shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bruker Corporation stock logo
BRKR
Bruker
-1.81%-4.60%+15.71%-19.43%-45.45%
Cambrex Co. stock logo
CBM
Cambrex
0.00%0.00%0.00%0.00%0.00%
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
-5.05%-6.55%-6.76%-5.64%-82.30%
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
-7.19%-4.70%+16.39%-3.40%-11.80%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bruker Corporation stock logo
BRKR
Bruker
$35.28
-1.8%
$32.98
$28.53
$65.25
$5.45B1.24.03 million shs3.70 million shs
Cambrex Co. stock logo
CBM
Cambrex
$59.99
$59.99
$33.80
$60.29
$2.02B2.14218,726 shsN/A
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
$0.42
-5.0%
$0.47
$0.28
$2.82
$19.68M1.521.08 million shs748,369 shs
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
$1.42
-7.2%
$1.31
$0.85
$2.72
$459.57M2.16.87 million shs8.72 million shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bruker Corporation stock logo
BRKR
Bruker
-1.81%-4.60%+15.71%-19.43%-45.45%
Cambrex Co. stock logo
CBM
Cambrex
0.00%0.00%0.00%0.00%0.00%
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
-5.05%-6.55%-6.76%-5.64%-82.30%
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
-7.19%-4.70%+16.39%-3.40%-11.80%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bruker Corporation stock logo
BRKR
Bruker
2.36
Hold$51.0044.56% Upside
Cambrex Co. stock logo
CBM
Cambrex
0.00
N/AN/AN/A
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
2.00
Hold$2.00376.64% Upside
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
2.25
Hold$1.9033.80% Upside

Current Analyst Ratings Breakdown

Latest CBM, BRKR, PACB, and HBIO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/8/2025
Bruker Corporation stock logo
BRKR
Bruker
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D+)
10/8/2025
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
10/8/2025
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
10/2/2025
Bruker Corporation stock logo
BRKR
Bruker
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$43.00 ➝ $40.00
9/27/2025
Bruker Corporation stock logo
BRKR
Bruker
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D+)
9/27/2025
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
9/27/2025
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
9/10/2025
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
Benchmark
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetSpeculative Buy$3.00 ➝ $2.00
8/11/2025
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$1.25 ➝ $1.50
8/5/2025
Bruker Corporation stock logo
BRKR
Bruker
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$60.00 ➝ $50.00
8/5/2025
Bruker Corporation stock logo
BRKR
Bruker
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetHold$48.00 ➝ $40.00
(Data available from 10/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bruker Corporation stock logo
BRKR
Bruker
$3.37B1.59$3.52 per share10.01$11.85 per share2.98
Cambrex Co. stock logo
CBM
Cambrex
$532.09M3.80$3.91 per share15.36$19.48 per share3.08
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
$94.14M0.20$0.10 per share4.38$1.45 per share0.29
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
$154.01M2.77N/AN/A$1.85 per share0.77
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bruker Corporation stock logo
BRKR
Bruker
$113.10M$0.5267.8511.205.002.31%17.89%5.38%11/4/2025 (Estimated)
Cambrex Co. stock logo
CBM
Cambrex
$92.41M$2.7721.66N/A5.96%5.38%2.50%N/A
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
-$12.40M-$1.30N/AN/A-64.68%-5.64%-2.15%11/6/2025 (Estimated)
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
-$309.85M-$2.29N/AN/AN/A-336.40%-66.75%-16.90%11/6/2025 (Estimated)

Latest CBM, BRKR, PACB, and HBIO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/6/2025Q3 2025
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
$0.0050N/AN/AN/A$20.00 millionN/A
11/6/2025Q3 2025
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
-$0.16N/AN/AN/A$40.25 millionN/A
11/4/2025Q3 2025
Bruker Corporation stock logo
BRKR
Bruker
$0.33N/AN/AN/A$847.40 millionN/A
8/7/2025Q2 2025
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
-$0.18-$0.13+$0.05-$0.14$36.35 million$39.77 million
8/4/2025Q2 2025
Bruker Corporation stock logo
BRKR
Bruker
$0.33$0.32-$0.01$0.05$811.17 million$797.40 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bruker Corporation stock logo
BRKR
Bruker
$0.200.57%N/A38.46%N/A
Cambrex Co. stock logo
CBM
Cambrex
N/AN/AN/AN/AN/A
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
N/AN/AN/AN/AN/A
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
N/AN/AN/AN/AN/A

Latest CBM, BRKR, PACB, and HBIO Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/7/2025
Bruker Corporation stock logo
BRKR
Bruker
quarterly$0.050.6%9/23/20259/23/202510/3/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bruker Corporation stock logo
BRKR
Bruker
1.31
1.61
0.70
Cambrex Co. stock logo
CBM
Cambrex
0.76
2.37
1.70
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
N/A
0.81
0.41
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
10.51
6.92
6.02

Institutional Ownership

CompanyInstitutional Ownership
Bruker Corporation stock logo
BRKR
Bruker
79.52%
Cambrex Co. stock logo
CBM
Cambrex
90.96%
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
80.87%
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
N/A

Insider Ownership

CompanyInsider Ownership
Bruker Corporation stock logo
BRKR
Bruker
27.30%
Cambrex Co. stock logo
CBM
Cambrex
1.41%
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
9.50%
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
2.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bruker Corporation stock logo
BRKR
Bruker
11,396151.72 million110.30 millionOptionable
Cambrex Co. stock logo
CBM
Cambrex
1,73233.72 millionN/AOptionable
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
49044.53 million40.30 millionOptionable
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
730300.37 million292.86 millionOptionable

Recent News About These Companies

Why Is PacBio (PACB) Stock Soaring Today

New MarketBeat Followers Over Time

Media Sentiment Over Time

Bruker stock logo

Bruker NASDAQ:BRKR

$35.28 -0.65 (-1.81%)
Closing price 10/10/2025 04:00 PM Eastern
Extended Trading
$34.80 -0.48 (-1.35%)
As of 10/10/2025 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Cambrex stock logo

Cambrex NYSE:CBM

Cambrex Corporation, a life sciences company, provides various products and services for the development and commercialization of new and generic therapeutics worldwide. Its products comprise active pharmaceutical ingredients and pharmaceutical intermediates that are used in the production of prescription and over-the-counter drug products, as well as finished dosage forms. The company serves generic drug companies; and companies that discover and commercialize small molecule human therapeutics. The company sells its products directly, as well as through independent agents. Cambrex Corporation was founded in 1981 and is headquartered in East Rutherford, New Jersey.

Harvard Bioscience stock logo

Harvard Bioscience NASDAQ:HBIO

$0.42 -0.02 (-5.05%)
Closing price 10/10/2025 04:00 PM Eastern
Extended Trading
$0.42 +0.00 (+1.05%)
As of 10/10/2025 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It also provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through sales organizations, websites, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic labs. It primarily sells its products under Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.

Pacific Biosciences of California stock logo

Pacific Biosciences of California NASDAQ:PACB

$1.42 -0.11 (-7.19%)
Closing price 10/10/2025 04:00 PM Eastern
Extended Trading
$1.40 -0.02 (-1.41%)
As of 10/10/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.